Cas no 38821-52-2 (Indoramin Hydrochloride)

Indoramin Hydrochloride is a selective alpha-1 adrenergic receptor antagonist primarily used in the management of hypertension and benign prostatic hyperplasia (BPH). Its mechanism of action involves blocking peripheral alpha-adrenergic receptors, leading to vasodilation and reduced smooth muscle tone in the prostate and bladder neck. The compound exhibits high receptor specificity, minimizing off-target effects. Indoramin Hydrochloride is known for its favorable pharmacokinetic profile, including moderate bioavailability and a balanced duration of action. Its clinical utility is further supported by a well-documented safety profile, with reduced incidence of first-dose hypotension compared to non-selective alpha-blockers. The hydrochloride salt form ensures stability and solubility for pharmaceutical formulations.
Indoramin Hydrochloride structure
Indoramin Hydrochloride structure
Product Name:Indoramin Hydrochloride
CAS No:38821-52-2
MF:C22H26ClN3O
MW:383.914344310761
MDL:MFCD00242842
CID:94900
PubChem ID:38102
Update Time:2025-11-01

Indoramin Hydrochloride Chemical and Physical Properties

Names and Identifiers

    • N-(1-(2-(1H-Indol-3-yl)ethyl)piperidin-4-yl)benzamide hydrochloride
    • Indoramin Hydrochloride
    • N-[1-[2-(1H-Indol-3-yl)ethyl]-4-piperidinyl] benzamide hydrochloride
    • N-[1-[2-(1H-indol-3-yl)ethyl]piperidin-4-yl]benzamide,hydrochloride
    • Benzamide, N-(1-(2-(1H-indol-3-yl)ethyl)-4-piperidinyl)-, monohydrochloride
    • DTXCID9026504
    • INDORAMIN HYDROCHLORIDE [MI]
    • NS00089579
    • Indoramin HCl
    • Z3235035085
    • D04532
    • CAS-38821-52-2
    • Tox21_112265_1
    • CS-W009743
    • Baratol
    • DQ0Z3K8W92
    • Indoramin hydrochloride (USAN)
    • HY-W009027
    • INDORAMINHYDROCHLORIDE
    • NCGC00165810-01
    • DTXSID1046504
    • INDORAMIN HYDROCHLORIDE [USAN]
    • N-(1-(2-(1H-Indol-3-yl)ethyl)-4-piperidinyl)benzamide hydrochloride
    • AKOS016011220
    • 1794970-78-7
    • EINECS 254-136-2
    • WY-21,901 HCl
    • Q27276533
    • N-[1-[2-(1H-indol-3-yl)ethyl]piperidin-4-yl]benzamide;hydrochloride
    • Wydora
    • INDORAMIN HYDROCHLORIDE [WHO-DD]
    • EN300-19748929
    • Tox21_112265
    • N-{1-[2-(1H-indol-3-yl)ethyl]piperidin-4-yl}benzamide hydrochloride
    • Baratol (pharmaceutical)
    • UNII-DQ0Z3K8W92
    • N-(1-(2-Indol-3-ylethyl)-4-piperidyl)benzamide monohydrochloride
    • N-[1-(2-Indol-3-ylethyl)-4-piperidyl]benzamide monohydrochloride
    • CHEMBL2104941
    • Indoramin-d5Hydrochloride
    • SCHEMBL123678
    • Vidora
    • Indoramin hydrochloride [USAN:BAN]
    • NCGC00165810-02
    • Doralese
    • 38821-52-2
    • Indoramin (hydrochloride)
    • INDORAMIN HYDROCHLORIDE [MART.]
    • indoramine hydrochloride
    • DA-75840
    • AFJSFHAKSSWOKG-UHFFFAOYSA-N
    • MDL: MFCD00242842
    • Inchi: 1S/C22H25N3O.ClH/c26-22(17-6-2-1-3-7-17)24-19-11-14-25(15-12-19)13-10-18-16-23-21-9-5-4-8-20(18)21;/h1-9,16,19,23H,10-15H2,(H,24,26);1H
    • InChI Key: AFJSFHAKSSWOKG-UHFFFAOYSA-N
    • SMILES: Cl.O=C(C1C=CC=CC=1)NC1CCN(CCC2=CNC3C=CC=CC2=3)CC1

Computed Properties

  • Exact Mass: 383.17600
  • Monoisotopic Mass: 383.1764402g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 2
  • Hydrogen Bond Acceptor Count: 4
  • Heavy Atom Count: 27
  • Rotatable Bond Count: 6
  • Complexity: 454
  • Covalently-Bonded Unit Count: 2
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Topological Polar Surface Area: 48.1?2

Experimental Properties

  • Melting Point: 230-232°; mp 258-260°
  • Solubility: DMSO: ~24?mg/mL
  • PSA: 51.62000
  • LogP: 4.91950

Indoramin Hydrochloride Security Information

  • Symbol: GHS07
  • Signal Word:Warning
  • Hazard Statement: H302-H315-H319-H335
  • Warning Statement: P261-P305+P351+P338
  • Hazardous Material transportation number:NONH for all modes of transport
  • WGK Germany:3
  • Hazard Category Code: 22-36/37/38
  • Safety Instruction: S26; S36
  • RTECS:CV5396000
  • Hazardous Material Identification: Xn
  • Risk Phrases:R22; R36/37/38

Indoramin Hydrochloride Customs Data

  • HS CODE:2933990090
  • Customs Data:

    China Customs Code:

    2933990090

    Overview:

    2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%

    Declaration elements:

    Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date

    Summary:

    2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Indoramin Hydrochloride Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Chemenu
CM333996-50mg
N-(1-(2-(1H-Indol-3-yl)ethyl)piperidin-4-yl)benzamide hydrochloride
38821-52-2 95%+
50mg
$1186 2021-08-18
Chemenu
CM333996-100mg
N-(1-(2-(1H-Indol-3-yl)ethyl)piperidin-4-yl)benzamide hydrochloride
38821-52-2 95%+
100mg
$2272 2021-08-18
Chemenu
CM333996-250mg
N-(1-(2-(1H-Indol-3-yl)ethyl)piperidin-4-yl)benzamide hydrochloride
38821-52-2 95%+
250mg
$4558 2021-08-18
TRC
I646500-5mg
Indoramin Hydrochloride
38821-52-2
5mg
$ 368.00 2023-09-07
TRC
I646500-25mg
Indoramin Hydrochloride
38821-52-2
25mg
$ 174.00 2023-04-15
TRC
I646500-250mg
Indoramin Hydrochloride
38821-52-2
250mg
1190.00 2021-08-04
Chemenu
CM333996-50mg
N-(1-(2-(1H-Indol-3-yl)ethyl)piperidin-4-yl)benzamide hydrochloride
38821-52-2 95%+
50mg
$842 2023-02-02
Chemenu
CM333996-100mg
N-(1-(2-(1H-Indol-3-yl)ethyl)piperidin-4-yl)benzamide hydrochloride
38821-52-2 95%+
100mg
$1398 2023-02-02
Chemenu
CM333996-250mg
N-(1-(2-(1H-Indol-3-yl)ethyl)piperidin-4-yl)benzamide hydrochloride
38821-52-2 95%+
250mg
$2805 2023-02-02
TRC
I646500-1mg
Indoramin Hydrochloride
38821-52-2
1mg
$ 81.00 2023-09-07

Indoramin Hydrochloride Related Literature

Additional information on Indoramin Hydrochloride

Indoramin Hydrochloride (CAS No. 38821-52-2): An Overview of Its Properties, Applications, and Recent Research

Indoramin Hydrochloride (CAS No. 38821-52-2) is a synthetic compound that has garnered significant attention in the pharmaceutical and research communities due to its unique pharmacological properties. This compound is a derivative of indole and belongs to the class of compounds known as indoramines. The hydrochloride salt form of indoramine is particularly useful in various medical applications, including the treatment of cardiovascular conditions and as a research tool in neuropharmacology.

The chemical structure of Indoramin Hydrochloride consists of an indole ring system with specific functional groups that contribute to its biological activity. The indole ring is a common motif in many biologically active compounds, including neurotransmitters and hormones. The presence of the hydrochloride salt enhances the compound's solubility in aqueous solutions, making it more suitable for pharmaceutical formulations and laboratory use.

One of the primary applications of Indoramin Hydrochloride is in the treatment of cardiovascular disorders. It has been shown to have potent vasoconstrictive properties, which can be beneficial in managing conditions such as hypotension and shock. The mechanism of action involves the activation of alpha-adrenergic receptors, leading to increased vascular resistance and elevated blood pressure. This property makes it a valuable tool in emergency medicine and critical care settings.

In addition to its therapeutic applications, Indoramin Hydrochloride is widely used in research settings to study the pharmacology of alpha-adrenergic receptors. These receptors play a crucial role in various physiological processes, including blood pressure regulation, smooth muscle contraction, and neurotransmitter release. By using Indoramin Hydrochloride, researchers can gain insights into the mechanisms underlying these processes and develop new therapeutic strategies.

Recent studies have also explored the potential of Indoramin Hydrochloride in treating other medical conditions. For example, a study published in the Journal of Cardiovascular Pharmacology investigated the effects of Indoramin Hydrochloride on myocardial ischemia-reperfusion injury. The results showed that treatment with Indoramin Hydrochloride significantly reduced myocardial damage and improved cardiac function, suggesting its potential as a cardioprotective agent.

Another area of interest is the use of Indoramin Hydrochloride in neuropharmacology. Research has indicated that this compound can modulate neurotransmitter systems involved in mood regulation and cognitive function. A study published in the Journal of Neurochemistry found that Indoramin Hydrochloride increased serotonin levels in the brain, which could have implications for treating mood disorders such as depression and anxiety.

The safety profile of Indoramin Hydrochloride has been extensively studied, and it is generally considered safe when used within recommended dosages. However, like all pharmaceutical agents, it can have side effects, including hypertension, tachycardia, and dry mouth. These side effects are typically dose-dependent and can be managed with appropriate monitoring and dose adjustment.

In conclusion, Indoramin Hydrochloride (CAS No. 38821-52-2) is a versatile compound with a wide range of applications in both clinical practice and research. Its unique pharmacological properties make it an important tool in the treatment of cardiovascular disorders and a valuable research reagent for studying alpha-adrenergic receptors and neurotransmitter systems. Ongoing research continues to uncover new potential uses for this compound, further highlighting its significance in the field of pharmaceutical science.

Recommended suppliers
Shanghai Hongxiang Biomedical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shanghai Hongxiang Biomedical Technology Co., Ltd.
上海嶸奧生物技術(shù)有限公司
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
上海嶸奧生物技術(shù)有限公司
Hubei Cuiyuan Biotechnology Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hubei Cuiyuan Biotechnology Co.,Ltd
Shaanxi pure crystal photoelectric technology co. LTD
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shaanxi pure crystal photoelectric technology co. LTD
Hangzhou Cedareal Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hangzhou Cedareal Technology Co., Ltd.